DR. PAMELA P. PALMER, M.D.
Osteopathic Medicine at Post St, San Francisco, CA
License number
California G79248
Category
Osteopathic Medicine
Type
Anesthesiology
License number
California G79248
Category
Osteopathic Medicine
Type
Pain Medicine
Address
Address
2255 Post St, San Francisco, CA 94115
Phone
(415) 885-7246
(415) 885-7575 (Fax)
(415) 885-7575 (Fax)
Personal information
See more information about PAMELA P. PALMER at radaris.comName
Address
Phone
4528 Canyon Rd, El Sobrante, CA 94803
409 N Palm Dr APT 101, Beverly Hills, CA 90210
4298 Dina Ct, Cypress, CA 90630
2240 Oconner Ave, Redding, CA 96001
1650 Jackson St, San Francisco, CA 94109
Professional information
Arthroscopic Irrigation Solution And Method For Peripheral Vasoconstriction And Inhibition Of Pain And Inflammation
US Patent:
7973068, Jul 5, 2011
Filed:
May 1, 2002
Appl. No.:
10/138192
Inventors:
Gregory A. Demopulos - Mercer Island WA, US
Pamela Pierce Palmer - San Francisco CA, US
Jeffrey M. Herz - Mill Creek WA, US
Pamela Pierce Palmer - San Francisco CA, US
Jeffrey M. Herz - Mill Creek WA, US
Assignee:
Omeros Corporation - Seattle WA
International Classification:
A61K 31/4174, A61P 25/00
US Classification:
514400
Abstract:
A method and solution for perioperatively inhibiting a variety of pain and inflammation processes during arthroscopic procedures. The solution preferably includes a vasoconstrictor that exhibits alpha-adrenergic activity and one or more additional pain and inflammation inhibitory agents at dilute concentration in a physiologic carrier, such as saline or lactated Ringer's solution. The solution is applied by continuous irrigation of a wound during a surgical procedure for peripheral vasoconstriction and inhibition of pain and/or inflammation while avoiding undesirable side effects associated with systemic application of larger doses of the agents.
Vascular Irrigation Solution And Method For Inhibition Of Pain, Inflammation, Spasm And Restenosis
US Patent:
2004012, Jul 1, 2004
Filed:
Sep 29, 2003
Appl. No.:
10/674290
Inventors:
Gregory Demopulos - Mercer Island WA, US
Pamela Palmer - San Francisco CA, US
Jeffrey Herz - Mill Creek WA, US
Pamela Palmer - San Francisco CA, US
Jeffrey Herz - Mill Creek WA, US
Assignee:
Omeros Corporation
International Classification:
A61M031/00
US Classification:
604/500000
Abstract:
A method and solution for perioperatively inhibiting a variety of pain, inflammation, spasm and restenosis processes resulting from cardiovascular or general vascular therapeutic and diagnostic procedures. The solution preferably includes multiple pain and inflammation inhibitory agents and spasm inhibitory agents at dilute concentration in a physiologic carrier, such as saline or lactated Ringer's solution. Specific preferred embodiments of the solution of the present invention for use in cardiovascular and general vascular procedures also include anti-restenosis agents. The solution is introduced luminally to continuously irrigate an arterial site during an operative/interventional or diagnostic procedure for preemptive inhibition of pain and inflammation, vascular and non-vascular smooth muscle spasm, and restenosis while avoiding undesirable side effects associated with oral, intramuscular, subcutaneous or intravenous application of larger doses of the agents. One preferred solution to inhibit pain, inflammation, vasospasm and restenosis includes a serotoninantagonist, a cyclooxygenase inhibitor, an endothelin antagonist, an ATP-sensitive K channel antagonist, a Ca channel antagonist, a nitric oxide donor, an anti-thrombin agent, a glycoprotein IIb/IIIa receptor blocker, a PKC inhibitor and a protein tyrosine kinase inhibitor.
Cardiovascular Compositions And Methods Using Combinations Of Anti-Platelet Agents
US Patent:
2008011, May 15, 2008
Filed:
Sep 6, 2007
Appl. No.:
11/899623
Inventors:
Gregory A. Demopulos - Mercer Island WA, US
Pamela Pierce Palmer - San Francisco CA, US
Jeffrey M. Herz - Mill Creek WA, US
Pamela Pierce Palmer - San Francisco CA, US
Jeffrey M. Herz - Mill Creek WA, US
International Classification:
A61K 31/4743, A61K 31/557
US Classification:
514301, 514573
Abstract:
A method and composition for inhibiting a variety of pain, inflammation, spasm and restenosis processes resulting from cardiovascular or general vascular therapeutic and diagnostic procedures. The composition preferably includes multiple pain and inflammation inhibitory agents and spasm inhibitory agents. Specific preferred embodiments of the solution of the present invention for use in cardiovascular and general vascular procedures also may include anti-restenosis agents.
Ophthalmologic Irrigation Solutions And Method
US Patent:
2013007, Mar 28, 2013
Filed:
Mar 14, 2012
Appl. No.:
13/420440
Inventors:
Gregory A. Demopulos - Mercer Island WA, US
Pamela Pierce Palmer - San Francisco CA, US
Jeffrey M. Herz - Mill Creek WA, US
Pamela Pierce Palmer - San Francisco CA, US
Jeffrey M. Herz - Mill Creek WA, US
Assignee:
OMEROS CORPORATION - Seattle WA
International Classification:
A61K 31/192, A61K 31/5377, A61K 31/137, A61K 31/167, A61K 45/06, A61K 31/4164, A61K 31/445
US Classification:
5142362, 514570, 514396, 514330, 514626, 514653
Abstract:
Solutions for perioperative intraocular application by continuous irrigation during ophthalmologic procedures are provided. These solutions include multiple agents that act to inhibit inflammation, inhibit pain, effect mydriasis (dilation of the pupil), and/or decrease intraocular pressure, wherein the multiple agents are selected to target multiple molecular targets to achieve multiple differing physiologic functions, and are included in dilute concentrations in a balanced salt solution carrier.
Small Volume Oral Transmucosal Dosage Forms Containing Sufentanil For Treatment Of Pain
US Patent:
8535714, Sep 17, 2013
Filed:
Oct 18, 2011
Appl. No.:
13/276165
Inventors:
Pamela Palmer - San Francisco CA, US
Thomas Schreck - Portola Valley CA, US
Lawrence Hamel - Pacific Grove CA, US
Stelio Tzannis - Petaluma CA, US
Andrew Poutiatine - Mill Valley CA, US
Thomas Schreck - Portola Valley CA, US
Lawrence Hamel - Pacific Grove CA, US
Stelio Tzannis - Petaluma CA, US
Andrew Poutiatine - Mill Valley CA, US
Assignee:
AcelRx Pharmaceuticals, Inc. - Redwood City CA
International Classification:
A61K 31/44
US Classification:
424464, 514329
Abstract:
Compositions, systems and methods for administration of small volume sufentanil drug dosage forms via the oral transmucosal route of a subject for treatment of pain.
Methods For Administering Small Volume Oral Transmucosal Dosage Forms Using A Dispensing Device
US Patent:
2008014, Jun 19, 2008
Filed:
Oct 30, 2007
Appl. No.:
11/980216
Inventors:
Pamela Palmer - San Francisco CA, US
Andrew I. Poutiatine - San Anselmo CA, US
Charles Rampersaud - San Francisco CA, US
Bruce Edwards - Menlo Park CA, US
Edmond Chiu - San Francisco CA, US
Thomas Schreck - Portola Valley CA, US
Stelios Tzannis - Newark CA, US
Larry Hamel - Mountain View CA, US
Andrew I. Poutiatine - San Anselmo CA, US
Charles Rampersaud - San Francisco CA, US
Bruce Edwards - Menlo Park CA, US
Edmond Chiu - San Francisco CA, US
Thomas Schreck - Portola Valley CA, US
Stelios Tzannis - Newark CA, US
Larry Hamel - Mountain View CA, US
Assignee:
AcelRx Pharmaceuticals, Inc. - Redwood City CA
International Classification:
A61M 31/00, G06K 5/00
US Classification:
604514, 604 77, 235381
Abstract:
Systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject using a device are disclosed. The dispensing device includes a lock-out feature and a means to retard or prevent saliva and/or moisture ingress such that the drug dosage forms in the device remain dry prior to administration.
Bioadhesive Drug Formulations For Oral Transmucosal Delivery
US Patent:
2013015, Jun 20, 2013
Filed:
Aug 27, 2012
Appl. No.:
13/595879
Inventors:
Stelios Tzannis - Petaluma CA, US
Larry Hamel - Pacific Grove CA, US
Pamela Palmer - San Francisco CA, US
Thomas Schreck - Portola Valley CA, US
Andrew I. Poutiatine - Mill Valley CA, US
Larry Hamel - Pacific Grove CA, US
Pamela Palmer - San Francisco CA, US
Thomas Schreck - Portola Valley CA, US
Andrew I. Poutiatine - Mill Valley CA, US
Assignee:
ACELRX PHARMACEUTICALS, INC. - Redwood City CA
International Classification:
A61K 9/00, A61K 31/4535
US Classification:
424435, 514326
Abstract:
Bioadhesive drug formulations that adhere to an oral mucosal membrane of a subject are provided together with single dose applicators and devices for delivering the drug formulations to the oral mucosa, and methods for using the same.
Cardiovascular Compositions And Methods Using Combinations Of Anti-Platelet Agents
US Patent:
2004021, Oct 28, 2004
Filed:
Jan 20, 2004
Appl. No.:
10/760639
Inventors:
Gregory Demopulos - Mercer Island WA, US
Pamela Palmer - San Francisco CA, US
Jeffrey Herz - Mill Creek WA, US
Pamela Palmer - San Francisco CA, US
Jeffrey Herz - Mill Creek WA, US
International Classification:
A61K031/4743, A61K031/557
US Classification:
514/301000, 514/573000
Abstract:
A method and composition for inhibiting a variety of pain, inflammation, spasm and restenosis processes resulting from cardiovascular or general vascular therapeutic and diagnostic procedures. The composition preferably includes multiple pain and inflammation inhibitory agents and spasm inhibitory agents. Specific preferred embodiments of the solution of the present invention for use in cardiovascular and general vascular procedures also may include anti-restenosis agents.
Rotational Intrathecal Analgesia
US Patent:
7737118, Jun 15, 2010
Filed:
Jul 1, 2002
Appl. No.:
10/187454
Inventors:
Gregory A. Demopulos - Mercer Island WA, US
Pamela Pierce Palmer - San Francisco CA, US
Pamela Pierce Palmer - San Francisco CA, US
Assignee:
Omeros Corporation - Seattle WA
Regents of the University of California - Oakland CA
Regents of the University of California - Oakland CA
International Classification:
A61K 38/10, A61K 31/485
US Classification:
514 13, 514282
Abstract:
A method of producing analgesia in a mammal is provided by rotational (alternating) intrathecal administration to the mammal of a pharmaceutically effective dose of at least one opioid receptor agonist, such as a μ-, δ-, or κ-opioid receptor agonist for a first period of time, followed by intrathecal administration to the mammal of a pharmaceutically effective dose of at least one opioid receptor-like receptor 1 (ORL-1) agonist for a second period of time. The intrathecal drug administration of the first and second periods of time may be repeated a plurality of times without attaining tolerance in the mammal to either drug. Implantable apparatus for rotational administration of the active agents is also disclosed.
Oral Transmucosal Administration Of Sufentanil
US Patent:
2011028, Nov 24, 2011
Filed:
May 21, 2010
Appl. No.:
12/784653
Inventors:
Pamela Palmer - San Francisco CA, US
Shamim Pushpala - Sunnyvale CA, US
Evangeline Cruz - Hayward CA, US
Larry Hamel - Mountain View CA, US
Linda Judge - Belmont CA, US
Shamim Pushpala - Sunnyvale CA, US
Evangeline Cruz - Hayward CA, US
Larry Hamel - Mountain View CA, US
Linda Judge - Belmont CA, US
Assignee:
AcelRx Pharmaceuticals, Inc. - Redwood City CA
International Classification:
A61K 31/4535, A61P 25/04, C07D 409/06
US Classification:
514326, 546213
Abstract:
Compositions and methods for administration of sufentanil-containing drug formulations to the oral mucosa of a subject are disclosed.